Fosun Pharma Buys Stake in India's Gland Pharma for $1.1B

Sep 18, 2017

Reuters

Shanghai Fosun Pharmaceutical Group reduced the size of the stake it will buy in India’s Gland Pharma to 74 percent, according to a Reuters article. Gland Pharma’s founding family reportedly wanted to retain a higher stake in the firm because it had good performance.

Fosun had been seeking an 86 percent stake valued at about $1.26 billion. But the company said in a statement to the stock exchange that the board had approved the new plan, which would involve investment of no more than $1.09 billion.

Read the Reuters story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments